Toronto Dominion Bank’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Buy
173,200
+124,158
+253% +$97.1K ﹤0.01% 1640
2025
Q4
$34.8K Sell
49,042
-958
-2% -$800 ﹤0.01% 1717
2025
Q3
$37.5K Sell
50,000
-7,794
-13% -$6.3K ﹤0.01% 1651
2025
Q2
$50.6K Buy
+57,794
New +$44.6K ﹤0.01% 1493

Other funds holding OACCW

Toronto Dominion Bank's OACCW Position: Q1 2026 in Review

Toronto Dominion Bank increased its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 253% in Q1 2026, buying an estimated $97.1K and bringing the position to 173,200 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Toronto Dominion Bank first reported a position in OACCW in Q2 2025 and has held it in 4 quarters since. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Toronto Dominion Bank held 173,200 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $130K as of Q1 2026.
  • Toronto Dominion Bank bought 124,158 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $97.1K.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1640 holding.
  • Toronto Dominion Bank first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q2 2025 and has held it in 4 quarters since.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.